Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases
Author:
Funder
National Institute on Aging
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s10620-023-08250-3.pdf
Reference39 articles.
1. Coward S, Clement F, Benchimol EI et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology 2019;156:1345-1353.e4.
2. Ananthakrishnan AN, Nguyen GC, Bernstein CN. AGA Clinical Practice update on management of inflammatory bowel disease in elderly patients: expert review. Gastroenterology 2021.
3. Mehta RS, Kochar BD, Kennelty K, et al. Emerging approaches to polypharmacy among older adults. Nature Aging 2021.
4. Kantor ED, Rehm CD, Haas JS et al. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA 2015;314:1818–1831.
5. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014;13:57–65.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Medical Management of Inflammatory Bowel Disease in the Elderly;Canadian IBD Today;2024-09-11
2. The IBD Clinic of Tomorrow: Holistic, Patient-Centric, and Value-based Care;Clinical Gastroenterology and Hepatology;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3